Current possibilities of predicting the development of pre-diabetes and type 2 diabetes mellitus

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Type 2 diabetes mellitus is a serious chronic disease that poses a serious public health problem since this pathology has a significant impact on health due to the high risk of occurrence and development of severe complications, which directly affects the socio-economic well-being of the population. The presented article analyzes the most significant links in the pathogenesis of type 2 diabetes mellitus, which makes it possible to determine the risk factors for its occurrence and development. The influence of obesity on disorders of carbohydrate metabolism, as well as other associated metabolic conditions, such as atherosclerosis, hypertension, dyslipidemia, has been emphasized. Anthropometric parameters and various indices are presented, allowing them to be assessed in relation to metabolic changes. The review summarizes the most convincing biochemical markers that have prognostic value in relation to the development of pre-diabetes and type 2 diabetes mellitus. The article pays special attention to the analysis and evidence base of the existing scales for assessing the risk of developing pre-diabetes and type 2 diabetes mellitus, including the first domestic calculator based on the DIARISK questionnaire. In addition, the article presents statistical data on the higher incidence of metabolic syndrome in people professionally associated with high psychoemotional load. However, the methods for assessing the risk of pre-diabetes and T2DM do not reflect the contribution of this factor to the development of carbohydrate metabolism disorders.

Full Text

Restricted Access

About the authors

Kirill V. Petrankov

Kirov Military Medical Academy

Author for correspondence.
Email: petrankovk@yandex.ru
ORCID iD: 0000-0001-7244-4303

graduate student at the 1st Department of Internal Medicine Postgraduate Training in endocrinology

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

Vladimir V. Salukhov

Kirov Military Medical Academy

Email: vlasaluk@yandex.ru
ORCID iD: 0000-0003-1851-0941
SPIN-code: 4531-6011

MD, Dr. Sci. (Med.)

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

Maxim I. Pugachev

Kirov Military Medical Academy

Email: kenig.max@mail.ru

MD, Cand. Sci. (Med.)

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

Larisa M. Dobrovolskaya

Kirov Military Medical Academy

Email: larisadobrovoskaja@mail.ru

MD, Cand. Sci. (Med.)

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

Tatyana V. Stepanova

Kirov Military Medical Academy

Email: stepanovatatyana1998@gmail.com
ORCID iD: 0000-0001-7177-2575
SPIN-code: 3580-0596

6th year cadet

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

Elizaveta A. Izilyaeva

Kirov Military Medical Academy

Email: izi_li55@bk.ru

the cadet

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

Sergej B. Shustov

Kirov Military Medical Academy

Email: sbs5555@mail.ru

профессор 1 кафедры (терапии усовершенствования врачей) доктор медицинских наук, профессор, Заслуженный врач Российской Федерации

Russian Federation, 6 Akademika Lebedeva St., Saint Peterburg, 194044

References

  1. Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes mellitus. 2016;19(2):104–112. (In Russ.). doi: 10.14341/DM2004116-17
  2. DeFronzo RA, Davidson JA, Del Prato S. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab. 2012;14(1):5–14. doi: 10.1111/j.1463-1326.2011.01511.x
  3. Salukhov VV, Romashevsky BV. Modern aspects for preventive therapy of type 2 diabetes mellitus. Medical Council. 2019;(4):6–13. (In Russ.). doi: 10.21518/2079-701X-2019-4-6-13
  4. Schwartz SS, Epstein S, Corkey BE, et al. The time is right for a new classification system for diabetes: rationale and implications of the β-Cell-Centric Classification Schema. Diabetes Care. 2016;39(2):179–186. doi: 10.2337/dc15-1585
  5. Salukhov VV, Khalimov YuS, Shustov SB, Kadin DV. Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies. Diabetes mellitus. 2018;21(3):193–205. (In Russ.). doi: 10.14341/DM9570
  6. Stumvoll M, Tataranni P., Stefan N, et al. Glucose allostasis. Diabetes. 2003;52(4):903–909. doi: 10.2337/diabetes.52.4.903
  7. Wright EM, Hirayama BA, Loo DF. Active sugar transport in health and disease. J Intern Med. 2007;261(1):32–43. doi: 10.1111/j.1365-2796.2006.01746.x
  8. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet. 2000;26(1):13. doi: 10.1038/79111
  9. Machann J, Häring H, Schick F, Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metab. 2004;6(4):239–248. doi: 10.1111/j.1462-8902.2004.00339.x
  10. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37(6):667–687. doi: 10.2337/diab.37.6.667
  11. Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS letters. 2008;582(1):117–131. doi: 10.1016/j.febslet.2007.11.051
  12. Ruan H, Lodish HF. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr Opin Lipidol. 2004;15(3):297–302. doi: 10.1097/00041433-200406000-00009
  13. Kern PA, Ranganathan S, Li C, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280(5):E745–751. doi: 10.1152/ajpendo.2001.280.5.E745
  14. Plomgaard P, Bouzakri K, Krogh-Madsen R, et al. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. 2005;54(10):2939–2945. doi: 10.2337/diabetes.54.10.2939
  15. Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2003;27(1):88–94. doi: 10.1038/sj.ijo.0802187
  16. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944–2950. doi: 10.2337/diabetes.51.10.2944
  17. Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350(7):664–671. doi: 10.1056/NEJMoa031314
  18. Lind MV, Savolainen OI, Ross AB. The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples. Eur J Epidemiol. 2016;31(8):717–733. doi: 10.1007/s10654-016-0166-2
  19. Herder C, Kowall B, Tabak AG, Rathmann W. The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia. 2014;57(1):16–29. doi: 10.1007/s00125-013-3061-3
  20. Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. 2013;62(12):4270–4276. doi: 10.2337/db13-0570
  21. Salukhov VV, Romashevskiy BV. Personalized medicine and its role in type 2 diabetes prevention. Emergency Cardiology and Cardiovascular risks. 2019;3(2):654–665. (In Russ.)
  22. Magnusson M, Wang TJ, Clish C, et al. Dimethylglycine deficiency and the development of diabetes. Diabetes. 2015;64(8):3010–3016. doi: 10.2337/db14-1863
  23. Savolainen O, Fagerberg B, Vendelbo Lind M, et al. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers? PloS One. 2017;12(7):e0177738. doi: 10.1371/journal.pone.0177738
  24. Sattar N, Wannamethee SG, Forouhi NG. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia. 2008;51(6):926–940. doi: 10.1007/s00125-008-0954-7
  25. Dorcely B, Katz K, Jagannathan R, et al. Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes Metab Syndr Obes. 2017;10:345–361. doi: 10.2147/DMSO.S100074
  26. Trocmé C, Gonnet N, Di Tommaso M, et al. Serum IRAP, a novel direct biomarker of prediabetes and type 2 diabetes? Front Mol Biosci. 2021;7:412. doi: 10.3389/fmolb.2020.596141
  27. Cepeda-Valery B, Pressman GS, Figueredo VM, Romero-Corral A. Impact of obesity on total and cardiovascular mortality – fat or fiction? Nat Rev Cardiol. 2011;8(4):233–237. doi: 10.1038/nrcardio.2010.209
  28. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–286. doi: 10.1111/j.1467-789X.2011.00952.x
  29. Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7( 7):e39504. doi: 10.1371/journal.pone.0039504
  30. Kislyak OA, Myshlyaeva TO, Malysheva NV. Sakharnyy diabet 2 tipa, arterial’naya gipertenziya i risk serdechno-sosudistykh oslozhneniy. Diabetes mellitus. 2008;11(1):45–49. (In Russ.). doi: 10.14341/2072-0351-5945
  31. Pierce M, Keen H, Bradley C. Risk of diabetes in offspring of parents with non-insulin-dependent diabetes. Diabet Med. 1995;12(1):6–13. doi: 10.1111/j.1464-5491.1995.tb02054.x
  32. Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017;84(7 Suppl 1):S15–S21. doi: 10.3949/ccjm.84.s1.03
  33. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–731. doi: 10.2337/diacare.26.3.725
  34. Mustafina SV, Rymar OD, Sazonova OV, et al. Validation of the Finnish diabetes risk score (FINDRISC) for the Caucasian population of Siberia. Diabetes mellitus. 2016;19(2):113–118. (In Russ.). doi: 10.14341/DM200418-10
  35. Glümer C, Carstensen B, Sandbaek A, et al. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care. 2004;27(3):727–733. doi: 10.2337/diacare.27.3.727
  36. Martin A, Neale EP, Tapsell LC. The clinical utility of the AUSDRISK tool in assessing change in type 2 diabetes risk in overweight/obese volunteers undertaking a healthy lifestyle intervention. Prev Med Rep. 2018;13:80–84. doi: 10.1016/j.pmedr.2018.11.020
  37. Schulze MB, Boeing H, Häring H-U. Validation of the German Diabetes Risk Score with metabolic risk factors for type 2 diabetes. Dtsch Med Wochenschr. 2008;133(17):878–883. (In German). doi: 10.1055/s-2008-1075664
  38. Liu M, Pan C, Jin M. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance. Diabetes Technol Ther. 2011;13(5):501–507. doi: 10.1089/dia.2010.0106
  39. Shestakova MV, Kolbin AS, Galstyan GR, et al. “DIARISK” – the first national prediabetes and diabetes mellitus type 2 risk calculator. Diabetes mellitus. 2020;23(5):404–411. (In Russ.). doi: 10.14341/DM12570
  40. Wilson PWF, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167(10):1068–1074. doi: 10.1001/archinte.167.10.1068
  41. Heppner PS, Crawford EF, Haji UA, et al. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med. 2009;7:1. doi: 10.1186/1741-7015-7-1
  42. Hartley TA, Sarkisian K, Violanti JM, et al. PTSD symptoms among police officers: associations with frequency, recency, and types of traumatic events. Int J Emerg Ment Health. 2013;15(4):241–253.
  43. Kryukov EV, Frolov DV, Kulikov AG, et al. New approaches to the rehabilitation of patients with diabetic angiopathy of the lower extremities. Military Medical Journal. 2020;341(1):38–44. (In Russ.)
  44. Kushnareva YuB, Patsenko MB, Oynotkinova Osh. Degree of manifestation of metabolic syndrome and of lipid metabolism disorders in people in hazardous occupations. Disaster Medicine. 2016;(2(94)):19–21. (In Russ.)
  45. Kryukov EV, Bulka KA, Chekhovskikh YuS, et al. Military medical organizations capability in delivery of specialized medical care in radiation emergencies. Bulletin of the Russian Military Medical Academy. 2021;23(1(73)):153–162. (In Russ.). doi: 10.17816/brmma63632

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Petrankov K.V., Salukhov V.V., Pugachev M.I., Dobrovolskaya L.M., Stepanova T.V., Izilyaeva E.A., Shustov S.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 71733 от 08.12.2017.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies